Roche’s Virtual Oncology/SABCS Investor Event
Roche has hosted a virtual event on Thursday, 11 December 2025
| Agenda | |
|---|---|
| Introduction | Bruno Eschli, Head of Investor Relations |
| Breast cancer franchise update | Maura Dickler, VP, Global Head for Breast & Gynecologic Cancers, Product Development |
| Ph III (lidERA) giredestrant in adjuvant ER+/HER2-negative, early BC | Aditya Bardia, MD, MPH, FASCO, Professor of Medicine, Geffen School of Medicine, University of California Los Angeles |
| Q&A |
Webinar Replay
Investors